Compare PTGX & UPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | UPST |
|---|---|---|
| Founded | 2006 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.7B |
| IPO Year | 2016 | 2020 |
| Metric | PTGX | UPST |
|---|---|---|
| Price | $105.55 | $34.74 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 16 |
| Target Price | ★ $108.23 | $45.84 |
| AVG Volume (30 Days) | 689.5K | ★ 4.2M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 131.25 |
| EPS | N/A | ★ 0.45 |
| Revenue | N/A | ★ $1,043,857,000.00 |
| Revenue This Year | $873.97 | $34.45 |
| Revenue Next Year | N/A | $32.64 |
| P/E Ratio | ★ N/A | $77.50 |
| Revenue Growth | N/A | ★ 63.99 |
| 52 Week Low | $41.29 | $23.97 |
| 52 Week High | $107.84 | $85.31 |
| Indicator | PTGX | UPST |
|---|---|---|
| Relative Strength Index (RSI) | 59.61 | 71.34 |
| Support Level | $76.63 | $34.23 |
| Resistance Level | $107.84 | $41.64 |
| Average True Range (ATR) | 4.03 | 1.58 |
| MACD | -0.12 | 1.21 |
| Stochastic Oscillator | 84.57 | 92.47 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Upstart Holdings Inc provides credit services. The company provides a proprietary, cloud-based, artificial intelligence lending platform. The platform aggregates consumer demand for loans and connects it to the network of Upstart AI-enabled bank partners. Upstart's platform includes personal loans, automotive retail and refinance loans, home equity lines of credit, and small-dollar loans.